406 related articles for article (PubMed ID: 29967007)
21. White Matter Lipids as a Ketogenic Fuel Supply in Aging Female Brain: Implications for Alzheimer's Disease.
Klosinski LP; Yao J; Yin F; Fonteh AN; Harrington MG; Christensen TA; Trushina E; Brinton RD
EBioMedicine; 2015 Dec; 2(12):1888-904. PubMed ID: 26844268
[TBL] [Abstract][Full Text] [Related]
22. Exercise modulates APOE expression in brain cortex of female APOE3 and APOE4 targeted replacement mice.
Mulgrave VE; Alsayegh AA; Jaldi A; Omire-Mayor DT; James N; Ntekim O; Walters E; Akala EO; Allard JS
Neuropeptides; 2023 Feb; 97():102307. PubMed ID: 36434832
[TBL] [Abstract][Full Text] [Related]
23. Apolipoprotein E isoform-specific regulation of dendritic spine morphology in apolipoprotein E transgenic mice and Alzheimer's disease patients.
Ji Y; Gong Y; Gan W; Beach T; Holtzman DM; Wisniewski T
Neuroscience; 2003; 122(2):305-15. PubMed ID: 14614898
[TBL] [Abstract][Full Text] [Related]
24. APOE modulates the effect of estrogen therapy on Aβ accumulation EFAD-Tg mice.
Kunzler J; Youmans KL; Yu C; Ladu MJ; Tai LM
Neurosci Lett; 2014 Feb; 560():131-6. PubMed ID: 24368217
[TBL] [Abstract][Full Text] [Related]
25. Human apoE3 but not apoE4 rescues impaired astrocyte activation in apoE null mice.
Ophir G; Meilin S; Efrati M; Chapman J; Karussis D; Roses A; Michaelson DM
Neurobiol Dis; 2003 Feb; 12(1):56-64. PubMed ID: 12609489
[TBL] [Abstract][Full Text] [Related]
26. Apolipoprotein E and Alzheimer's disease: a review of recent studies.
Higgins GA; Large CH; Rupniak HT; Barnes JC
Pharmacol Biochem Behav; 1997 Apr; 56(4):675-85. PubMed ID: 9130294
[TBL] [Abstract][Full Text] [Related]
27. Reduction in DHA transport to the brain of mice expressing human APOE4 compared to APOE2.
Vandal M; Alata W; Tremblay C; Rioux-Perreault C; Salem N; Calon F; Plourde M
J Neurochem; 2014 May; 129(3):516-26. PubMed ID: 24345162
[TBL] [Abstract][Full Text] [Related]
28. Retinoic acid isomers facilitate apolipoprotein E production and lipidation in astrocytes through the retinoid X receptor/retinoic acid receptor pathway.
Zhao J; Fu Y; Liu CC; Shinohara M; Nielsen HM; Dong Q; Kanekiyo T; Bu G
J Biol Chem; 2014 Apr; 289(16):11282-11292. PubMed ID: 24599963
[TBL] [Abstract][Full Text] [Related]
29. The interaction of amyloid-beta with ApoE.
Carter DB
Subcell Biochem; 2005; 38():255-72. PubMed ID: 15709483
[TBL] [Abstract][Full Text] [Related]
30. Alzheimer's Risk Factors Age, APOE Genotype, and Sex Drive Distinct Molecular Pathways.
Zhao N; Ren Y; Yamazaki Y; Qiao W; Li F; Felton LM; Mahmoudiandehkordi S; Kueider-Paisley A; Sonoustoun B; Arnold M; Shue F; Zheng J; Attrebi ON; Martens YA; Li Z; Bastea L; Meneses AD; Chen K; Thompson JW; St John-Williams L; Tachibana M; Aikawa T; Oue H; Job L; Yamazaki A; Liu CC; Storz P; Asmann YW; Ertekin-Taner N; Kanekiyo T; Kaddurah-Daouk R; Bu G
Neuron; 2020 Jun; 106(5):727-742.e6. PubMed ID: 32199103
[TBL] [Abstract][Full Text] [Related]
31. Human apolipoprotein E isoforms are differentially sialylated and the sialic acid moiety in ApoE2 attenuates ApoE2-Aβ interaction and Aβ fibrillation.
Moon HJ; Haroutunian V; Zhao L
Neurobiol Dis; 2022 Mar; 164():105631. PubMed ID: 35041991
[TBL] [Abstract][Full Text] [Related]
32. Peripheral apoE4 enhances Alzheimer's pathology and impairs cognition by compromising cerebrovascular function.
Liu CC; Zhao J; Fu Y; Inoue Y; Ren Y; Chen Y; Doss SV; Shue F; Jeevaratnam S; Bastea L; Wang N; Martens YA; Qiao W; Wang M; Zhao N; Jia L; Yamazaki Y; Yamazaki A; Rosenberg CL; Wang Z; Kong D; Li Z; Kuchenbecker LA; Trottier ZA; Felton L; Rogers J; Quicksall ZS; Linares C; Knight J; Chen Y; Kurti A; Kanekiyo T; Fryer JD; Asmann YW; Storz P; Wang X; Peng J; Zhang B; Kim BYS; Bu G
Nat Neurosci; 2022 Aug; 25(8):1020-1033. PubMed ID: 35915180
[TBL] [Abstract][Full Text] [Related]
33. Total Cholesterol and APOE-Related Risk for Alzheimer's Disease in the Alzheimer's Disease Neuroimaging Initiative.
Dunk MM; Driscoll I;
J Alzheimers Dis; 2022; 85(4):1519-1528. PubMed ID: 34958023
[TBL] [Abstract][Full Text] [Related]
34. Isoform-Specific Effects of Apolipoprotein E on Markers of Inflammation and Toxicity in Brain Glia and Neuronal Cells In Vitro.
Iannucci J; Sen A; Grammas P
Curr Issues Mol Biol; 2021 May; 43(1):215-225. PubMed ID: 34071762
[TBL] [Abstract][Full Text] [Related]
35. Impact of apolipoprotein E (ApoE) polymorphism on brain ApoE levels.
Riddell DR; Zhou H; Atchison K; Warwick HK; Atkinson PJ; Jefferson J; Xu L; Aschmies S; Kirksey Y; Hu Y; Wagner E; Parratt A; Xu J; Li Z; Zaleska MM; Jacobsen JS; Pangalos MN; Reinhart PH
J Neurosci; 2008 Nov; 28(45):11445-53. PubMed ID: 18987181
[TBL] [Abstract][Full Text] [Related]
36. Differential interaction of Apolipoprotein-E isoforms with insulin receptors modulates brain insulin signaling in mutant human amyloid precursor protein transgenic mice.
Chan ES; Chen C; Cole GM; Wong BS
Sci Rep; 2015 Sep; 5():13842. PubMed ID: 26346625
[TBL] [Abstract][Full Text] [Related]
37. 2-Deoxy-D-glucose treatment induces ketogenesis, sustains mitochondrial function, and reduces pathology in female mouse model of Alzheimer's disease.
Yao J; Chen S; Mao Z; Cadenas E; Brinton RD
PLoS One; 2011; 6(7):e21788. PubMed ID: 21747957
[TBL] [Abstract][Full Text] [Related]
38. Apolipoprotein E isoforms differentially regulate matrix metallopeptidase 9 function in Alzheimer's disease.
Ringland C; Schweig JE; Paris D; Shackleton B; Lynch CE; Eisenbaum M; Mullan M; Crawford F; Abdullah L; Bachmeier C
Neurobiol Aging; 2020 Nov; 95():56-68. PubMed ID: 32758917
[TBL] [Abstract][Full Text] [Related]
39. Altered Energy Metabolism Pathways in the Posterior Cingulate in Young Adult Apolipoprotein E ɛ4 Carriers.
Perkins M; Wolf AB; Chavira B; Shonebarger D; Meckel JP; Leung L; Ballina L; Ly S; Saini A; Jones TB; Vallejo J; Jentarra G; Valla J
J Alzheimers Dis; 2016 Apr; 53(1):95-106. PubMed ID: 27128370
[TBL] [Abstract][Full Text] [Related]
40. APOΕ4 lowers energy expenditure in females and impairs glucose oxidation by increasing flux through aerobic glycolysis.
Farmer BC; Williams HC; Devanney NA; Piron MA; Nation GK; Carter DJ; Walsh AE; Khanal R; Young LEA; Kluemper JC; Hernandez G; Allenger EJ; Mooney R; Golden LR; Smith CT; Brandon JA; Gupta VA; Kern PA; Gentry MS; Morganti JM; Sun RC; Johnson LA
Mol Neurodegener; 2021 Sep; 16(1):62. PubMed ID: 34488832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
